KaloBios Names Controversial Martin Shkreli As Its New CEO By: Benzinga via Benzinga November 20, 2015 at 08:45 AM EST Shares of KaloBios Pharmaceuticals Inc (NASDAQ: KBIO) rose more than 400 percent on Thursday after the company announced Martin ... Read More >>